Carregant...
Efficacy of Miltefosine for the Treatment of American Cutaneous Leishmaniasis
Miltefosine is an oral agent used for cutaneous leishmaniasis treatment. An open-label, randomized, phase III clinical trial was carried out in the Colombian army population. Miltefosine, 50 mg capsule was taken orally three times per day for 28 days (N = 145) or meglumine antimoniate, 20 mg/kg body...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The American Society of Tropical Medicine and Hygiene
2010
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2911184/ https://ncbi.nlm.nih.gov/pubmed/20682881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2010.10-0060 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|